Todd Foley is Director at Repare Therapeutics Inc. (RPTX). They have made 42 open-market trades across 8 companies since 2013, most recently 2026-01-12.
CIK 0001473930
7 open-market purchases totalling $25.6M since 2013, against 35 sales. Across 5 scored buys the stock is down 18.1% at ninety days, and 20.8 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 20% | 20% |
| Avg Move | +1.6% | -13.2% | -18.1% |
| Alpha | +0.3% | -14.4% | -20.8% |
| Scored | 5 | 5 | 5 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 20% | 20% | 40% |
| Avg Move | -6.1% | +6.7% | +21.4% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AKTS | BUY | 2026-01-12 | 2026-01-14 | $18.00 | $4.2M | +0.8% | -15.7% | -15.3% |
| TRDA | BUY | 2021-11-02 | 2021-11-04 | $20.00 | $2.0M | +35.0% | -12.1% | -62.8% |
| ITOS | SELL | 2021-10-07 | 2021-10-12 | $27.23 | $2.8M | +1.6% | +10.3% | +55.1% |
| ITOS | SELL | 2021-09-16 | 2021-09-20 | $28.38 | $5.2M | +0.1% | +2.4% | +60.6% |
| RPTX | SELL | 2021-07-09 | 2021-07-13 | $33.55 | $1.8M | -1.7% | +0.2% | -42.0% |
| RPTX | SELL | 2021-06-28 | 2021-06-30 | $34.06 | $495K | +8.6% | +6.6% | -15.4% |
| RPTX | SELL | 2021-06-24 | 2021-06-28 | $33.51 | $847K | -1.8% | +2.9% | -19.0% |
| RPTX | SELL | 2021-06-21 | 2021-06-23 | $34.43 | $1.2M | -3.3% | +0.6% | -13.4% |
| RPTX | SELL | 2021-06-17 | 2021-06-21 | $33.75 | $1.2M | -10.2% | -1.4% | -18.4% |
| RPTX | SELL | 2021-06-14 | 2021-06-16 | $33.28 | $153K | +1.8% | -4.7% | -6.8% |
| RPTX | SELL | 2021-06-08 | 2021-06-10 | $34.05 | $1.8M | -3.8% | +0.8% | -5.8% |
| RPTX | SELL | 2021-06-03 | 2021-06-07 | $32.04 | $1.6M | +2.3% | -3.5% | -5.5% |
| RPTX | SELL | 2021-05-28 | 2021-06-02 | $32.47 | $1.1M | +3.0% | -2.3% | +6.9% |
| RPTX | SELL | 2021-05-25 | 2021-05-27 | $32.82 | $1.1M | +7.7% | +4.7% | +7.7% |
| RPTX | SELL | 2021-05-21 | 2021-05-24 | $34.75 | $9.9M | -8.6% | -3.2% | -0.4% |
| RPTX | SELL | 2021-05-18 | 2021-05-20 | $34.33 | $1.3M | -7.2% | +0.1% | -2.9% |
| RYTM | SELL | 2021-03-15 | 2021-03-16 | $25.10 | $25.1M | -15.6% | -18.9% | -18.8% |
| RPTX | SELL | 2021-03-12 | 2021-03-15 | $28.18 | $21.2M | +4.9% | +19.5% | +14.3% |
| RYTM | SELL · 10b5-1 | 2020-06-26 | 2020-06-30 | $25.04 | $8K | -7.1% | -11.0% | +0.2% |
| RYTM | SELL | 2020-06-24 | 2020-06-25 | $25.35 | $5.8M | -11.4% | -13.9% | +1.9% |
| RPTX | BUY | 2020-06-23 | 2020-06-25 | $20.00 | $5.0M | -14.8% | -34.0% | -0.8% |
| RYTM | SELL · 10b5-1 | 2020-06-05 | 2020-06-05 | $20.00 | $38K | +5.7% | +7.4% | +45.0% |
| RYTM | SELL | 2020-06-01 | 2020-06-03 | $20.21 | $1.8M | +4.0% | +9.9% | +45.7% |
| RYTM | SELL | 2020-05-27 | 2020-05-28 | $20.17 | $1.2M | +5.8% | +10.3% | -3.4% |
| RYTM | SELL | 2020-05-21 | 2020-05-26 | $20.32 | $3.9M | +1.4% | +24.5% | -9.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| CNAT | 1,026,815 | — |
| CLDN | 955,167 | — |
| Total | $223.1M |
Shares reported on the most recent Form 4, priced at the 2026-01-14 close. 2 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Scored | 5 | 5 | 5 |